Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

10.05
Delayed Data
As of Apr 20
 +0.15 / +1.52%
Today’s Change
8.34
Today|||52-Week Range
16.50
-29.82%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close9.90
Today’s open9.98
Day’s range9.59 - 10.12
Volume493,328
Average volume (3 months)779,260
Market cap$412.2M
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+40.35%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+48.05%
P/E ratio18.3
Price/Sales9.93
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.25-2.21%
PRTKParatek Pharmaceutic...-0.06-0.21%
AMPEAmpio Pharmaceutical...-5.18-65.82%
IDRAIdera Pharmaceutical...+0.11+3.19%
Data as of 04/20/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$50.2M
Annual profit (last year)$20.2M
Net profit margin40.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers